mynth
06/2017MajorityLBO

ICG & Management & Private Investors take majority stake in Domusvi

FRANCE Health Providers / Healthcare Facilities / Nursing Homes EV €1–10bn

Context

ICG and founder Yves Journel have entered into exclusive negotiations to acquire the majority stake in DomusVi from PAI Partners. The transaction follows a preemptive bid by ICG that successfully bypassed a formal auction process involving major international investors and sovereign funds. This deal marks a significant change in scale for the group, which was valued at less than €650 million in 2014. The acquisition is structured to maintain the existing high-yield bond financing, as the continued presence of ICG and the founder in the capital prevents the activation of change-of-control repayment clauses. The strategic rationale centers on pursuing the international expansion of the group, particularly in markets like Spain, where the recent integration of SARquavitae has already propelled the company to a leadership position. The partnership intends to bridge the gap with major competitors such as Orpea and Korian-Medica by leveraging DomusVi's strong expertise in specialized care and home services.

Domusvi, which reported an EBITDA margin of [members only] in 2017, is valued in this transaction at an EV/EBITDA multiple of 10x–18x.

-> Deep-dive in Healthcare & Pharma market trends

Target

DomusVi stands as a leading international provider of high-quality elderly care and specialized services. The group operates an extensive cross-border network across Europe and Latin America, encompassing medicalized nursing homes, mental health facilities, and home care agencies. The entity actively executes a targeted buy-and-build strategy aimed at securing and strengthening its premier position within its domestic market. DomusVi’s value proposition is built upon a multi-disciplinary approach to dependency and senior care, seamlessly integrating medicalized residential care, specialized disability centers, and home assistance solutions to deliver a comprehensive support ecosystem for seniors and their families.

Ent. Value

€1–10bn

Equity Value

[members only]

Multiples

EV / Revenue

1x–3x

EV / EBITDA

10x–18x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2017
€1–10bn
€100–200M
[members only]
2016
€1–10bn
€100–200M
[members only]

Other operations with Domusvi

Other operations with Domusvi
DateAcquirerTargetCountrySector
04/2021ICG / MANAGEMENT & PRIVATE INVESTORSDOMUSVIFRANCENursing Homes
03/2019DOMUSVIRESIDALYAFRANCENursing Homes
10/2016DOMUSVISARQUAVITAESPAINNursing Homes
06/2014PAI PARTNERSDOMUSVIFRANCENursing Homes

Other operations with ICG / Management & Private Investors

Other operations with ICG / Management & Private Investors
DateAcquirerTargetCountrySector
08/2018MANAGEMENT & PRIVATE INVESTORSDESIGUALSPAINFashion & Apparel
07/2018MANAGEMENT & PRIVATE INVESTORSBETJEMAN & BARTONFRANCECoffee & Tea
06/2017HG CAPITAL / GIC / MONTAGU PRIVATE EQUITY / ICGVISMA GROUPNORWAYERP, HR & Finance
12/2016ICGPARK HOLIDAYSUNITED KINGDOMHospitality
09/2015ICGCOURTEPAILLEFRANCERestaurants / Chains
06/2015ICGSTELLAFRANCEExternal Joinery
02/2014ICGAPEM GROUPFRANCEElectrical Equipment
07/2012MANAGEMENT & PRIVATE INVESTORSLVL MEDICAL GERMANYGERMANYOutpatient Care
03/2012MANAGEMENT & PRIVATE INVESTORSICELAND FOODS GROUPUNITED KINGDOMGeneral Grocery
02/2011ICGGERFLORFRANCEFlooring

Similar deals in Health Providers

Similar deals in Health Providers
DateAcquirerTargetCountrySector
03/2018ICV PARTNERSOUTPATIENT IMAGING AFFILIATESUNITED STATESRadiology
01/2018PERMIRAI-MED RADIOLOGY NETWORKAUSTRALIARadiology
05/2017BC PARTNERSDENTALPROITALYDental Centers
04/2017EQT PARTNERSCOLISÉEFRANCENursing Homes
01/2017MARSVCAUNITED STATESVet Clinics
01/2017PARTNERS GROUP / PSP INVESTMENTSCERBA HEALTHCAREFRANCELabs (Biology)
10/2016DOMUSVISARQUAVITAESPAINNursing Homes
05/2016VCACOMPANION ANIMAL PRACTICESUNITED STATESVet Clinics
03/2016F2I SGR / CIR - COMPAGNIE INDUSTRIALI RIUNITEKOS GROUPITALYNursing Homes
02/2016OMERSFOREFRONT DERMATOLOGYUNITED STATESOutpatient Care

REFERENCES

Valuation range: EV €1–10bn

Revenue range: €1–10bn

EBITDA range: €100–200M

EV/Revenue range: 1x - 3x

EV/EBITDA range: 10x - 18x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Domusvi by ICG / Management & Private Investors are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

FAQ

What transaction does this page cover?

This page covers the acquisition of a majority stake in Domusvi, a French company specialised in Healthcare Facilities, by ICG and Management & Private Investors in 2017, structured as a leveraged buyout (LBO). This followed a prior holding cycle initiated by PAI Partners in June 2014, before ownership was subsequently transferred to ICG / Management & Private Investors in April 2021 (see dedicated deal pages for details).

How was the acquisition of Domusvi by ICG valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the €1–10bn band, its EV/EBITDA multiple within the 10x - 18x range, and its EV/revenue multiple within the 1x - 3x range. Exact figures are available to members.

What were Domusvi’s revenue and EBITDA at the time of the deal?

At the time of the transaction, Domusvi generated annual revenue estimated in the €1–10bn range and EBITDA in the €100–200M bracket (FY 2017). Detailed financial figures are available to members.

What sources support the information on this transaction?

Transaction intelligence is supported by independent reporting from specialized financial publications, alongside a private document shared by the community and verified by the mynth team to ensure the accuracy of the shared information.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.